Background: I will present a quick look at outcome disparities and some specific cases where there is a clear biologic basis for outcome disparities in cancer. It would also be relevant to look at some statistics of the racial makeup of participants in clinical trials.

Data: I will incorporate the survey results from a high school student (who will be listed as a coauthor) that will address attitudes toward clinical trial participation, stratified by race. I will also present some of the strategies that a team I am leading at Howard University hopes to employ as they use social media and local outreach to increase enrollment of African American patients in the MBC project.

Citation Format: Jamie Holloway. [Advocate Abstract:] Culturally sensitive outreach for clinical trials and research studies is key to addressing biologic contributors to health disparities [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr A17.